Mid-Atlantic BioTherapeutics' Unattributed Round

Mid-Atlantic BioTherapeutics raised a round of funding on October 11, 2018.

Mid-Atlantic BioTherapeutics was founded with the mission of eradicating infectious diseases using a patented technology platform called IMT504.…

Articles about Mid-Atlantic BioTherapeutics' Unattributed Round: